Efficacy and safety of RC48-ADC in HER2-positive and HER2-low metastatic breast cancer: a multicenter, real-world study by Fei Qu, Fei Qu, Rongrong Lu, Rongrong Lu, Xinyu Wu, Xinyu Wu, Qian Liu, Qian Liu, Mengyao Zha, Mengyao Zha, Huihui Li, Yuan Yuan, Zhengxiang Han, Dongyan Cai, Xiang Huang, Yongmei Yin, Yongmei Yin, Wei Li

Get full text